[go: up one dir, main page]

DE60029624D1 - Homologe enzyme der humanen heparanase sowie alternative spleissformen davon - Google Patents

Homologe enzyme der humanen heparanase sowie alternative spleissformen davon

Info

Publication number
DE60029624D1
DE60029624D1 DE60029624T DE60029624T DE60029624D1 DE 60029624 D1 DE60029624 D1 DE 60029624D1 DE 60029624 T DE60029624 T DE 60029624T DE 60029624 T DE60029624 T DE 60029624T DE 60029624 D1 DE60029624 D1 DE 60029624D1
Authority
DE
Germany
Prior art keywords
format
alternative splice
human heparanase
homologous enzymes
heparanase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029624T
Other languages
English (en)
Other versions
DE60029624T2 (de
Inventor
Alexander Mckenzie
Craig Stamps
Alexander Terrett
Louise Tyson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9930392.7A external-priority patent/GB9930392D0/en
Priority claimed from GB0008713A external-priority patent/GB0008713D0/en
Application filed by UCB SA filed Critical UCB SA
Application granted granted Critical
Publication of DE60029624D1 publication Critical patent/DE60029624D1/de
Publication of DE60029624T2 publication Critical patent/DE60029624T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01166—Heparanase (3.2.1.166)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
DE60029624T 1999-12-22 2000-12-21 Homologe enzyme der humanen heparanase sowie alternative spleissformen davon Expired - Lifetime DE60029624T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9930392.7A GB9930392D0 (en) 1999-12-22 1999-12-22 Substances
GB9930392 1999-12-22
GB0008713 2000-04-07
GB0008713A GB0008713D0 (en) 2000-04-07 2000-04-07 Substances
PCT/GB2000/004963 WO2001046392A2 (en) 1999-12-22 2000-12-21 Homologues of human heparanase and splice variants thereof

Publications (2)

Publication Number Publication Date
DE60029624D1 true DE60029624D1 (de) 2006-09-07
DE60029624T2 DE60029624T2 (de) 2007-08-09

Family

ID=26244068

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029624T Expired - Lifetime DE60029624T2 (de) 1999-12-22 2000-12-21 Homologe enzyme der humanen heparanase sowie alternative spleissformen davon

Country Status (11)

Country Link
US (2) US7273744B2 (de)
EP (1) EP1240313B1 (de)
JP (1) JP2003517835A (de)
AT (1) ATE334194T1 (de)
AU (1) AU2207801A (de)
CA (1) CA2393855A1 (de)
DE (1) DE60029624T2 (de)
DK (1) DK1240313T3 (de)
ES (1) ES2269211T3 (de)
IL (1) IL149889A0 (de)
WO (1) WO2001046392A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072973A2 (en) * 2000-02-24 2001-10-04 Bayer Aktiengesellschaft Regulation of human heparanase-like enzyme
GB0008912D0 (en) * 2000-04-11 2000-05-31 Janssen Pharmaceutica Nv Mammalian heparanase
US20020064853A1 (en) * 2000-04-20 2002-05-30 Heinrikson Robert Leroy Heparanase II, a novel human heparanase paralog
WO2002004645A2 (en) * 2000-07-12 2002-01-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A second human heparanase, and splice variants thereof, with a predominant expression in skeletal muscle, heart and pancreas
WO2002090574A1 (en) * 2001-05-09 2002-11-14 Insight Biopharmaceuticals Ltd. Methods and kits utilizing heparanase as a diagnostic marker for haemostatic disorders
EP1786908B1 (de) * 2004-08-18 2010-03-03 Bayer CropScience AG Pflanzen mit erhöhter plastidär aktivität der stärkephosphorylierenden r3-enzyme
EP1968379A2 (de) * 2005-12-12 2008-09-17 Riolan Technologies, Inc. Zusammensetzungen, verfahren und kits zur entfernung von trümmern aus einem augenbereich
EP3558363A1 (de) 2016-12-21 2019-10-30 Amgen Inc. Anti-tnf-alpha-antikörperformulierungen

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79255A0 (en) 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
WO1995013830A1 (en) 1993-11-17 1995-05-26 Massachusetts Institute Of Technology Method for inhibiting angiogenesis using heparinase
JP3713276B2 (ja) 1995-09-29 2005-11-09 バイオマリン ファーマシューティカル インコーポレイテッド 炎症反応の軽減のためのヘパリナーゼの使用
US5968822A (en) 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
BR9813296A (pt) * 1997-10-28 2000-08-22 Univ Australian Molécula isolada de ácido nucleico, processo para identificar uma molécula de ácido nucleico codificando um polipeptìdeo de endoglucuronidase de mamìfero, vetor de expressão, peptìdeo de heparanase isolado, polipeptìdeo recombinante ou isolado, molécula de anticorpo, processo para identificar um modulador da atividade de heparanase, uso de um oligossacarìdeo sulfatado, um sulfonato ou hspg compreendendo os mesmos, processos para tratamento de uma condição fisiológica ou médica em um sujeito humano ou animal em que a atividade de heparanase no referido sujeito é elevada, para intensificar a cura de feridas em um sujeito humano ou animal e para diagnosticar uma condição fisiológica ou médica associada com a super-expressão de heparanase, e, célula
GB9802725D0 (en) 1998-02-09 1998-04-08 Ciba Geigy Ag Organic compounds
EP1060252A2 (de) 1998-02-24 2000-12-20 PHARMACIA & UPJOHN COMPANY Menschliche plättchen heparanase polypeptide, dafür kodierende polynukleotide, und verfahren zum nachweis von verbindungen die heparinase-aktivität ändern
US7101706B1 (en) * 1999-06-25 2006-09-05 Insight Biopharmaceuticals Ltd. Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
CA2377498A1 (en) * 1999-06-25 2001-01-04 Insight Strategy & Marketing Ltd. Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
WO2001021814A1 (en) * 1999-09-23 2001-03-29 Merck Patent Gmbh Heparanase-2, a member of the heparanase protein family
AU2001253323A1 (en) * 2000-04-18 2001-10-30 Human Genome Sciences, Inc. Extracellular matrix polynucleotides, polypeptides, and antibodies

Also Published As

Publication number Publication date
ATE334194T1 (de) 2006-08-15
JP2003517835A (ja) 2003-06-03
EP1240313A2 (de) 2002-09-18
AU2207801A (en) 2001-07-03
WO2001046392A3 (en) 2001-12-06
DE60029624T2 (de) 2007-08-09
ES2269211T3 (es) 2007-04-01
CA2393855A1 (en) 2001-06-28
US20090246201A1 (en) 2009-10-01
WO2001046392A2 (en) 2001-06-28
US20030083254A1 (en) 2003-05-01
US7273744B2 (en) 2007-09-25
EP1240313B1 (de) 2006-07-26
IL149889A0 (en) 2002-11-10
DK1240313T3 (da) 2006-11-27

Similar Documents

Publication Publication Date Title
FI942624A0 (fi) Alfa-heteroaryylioksimetyyliketoneja interleukiini-1betaa muuttavan entsyymin inhibiittoreina
NO20004219L (no) Inhibitorer av fosfolipaseenzymer
NO20004220L (no) Inhibitorer av fosfolipaseenzymer
DE60013098D1 (de) Zusammensetzung zur hautdesinfizierung
NO20005293L (no) Visse tiolininhibitorer av endotelinomdannende enzym
AU2002325782A1 (en) Pharmaceutical composition and method of treatment of human malignancies with arginine deprivation
DE60029624D1 (de) Homologe enzyme der humanen heparanase sowie alternative spleissformen davon
AU6949200A (en) Human hydrolytic enzymes
AU2002221755A1 (en) Nucleotide and polypeptide sequence of human lysosomal acid lipase
AU2001250193A1 (en) Novel pyridones and their use as modulators of serine hydrolase enzymes
DE69927048D1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
DK1079834T3 (da) Stabile sammensætninger omfattende levosimendan og alginsyre
AU2001274080A1 (en) Regulation of human transketolase-like enzyme
AU2001281939A1 (en) Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme
AU2001295602A1 (en) Regulation of human phospholipase a2-like enzyme
AU2001293780A1 (en) Regulation of human protein phosphatase iic-like enzyme
AU2002212246A1 (en) Regulation of human serine palmitoyltransferase-like enzyme
ITRM990787A0 (it) Idrolisi stereospecifica di esteri otticamente attivi.
PT1196606E (pt) Enzima litica
AU2002212318A1 (en) Regulation of human phospholipase a2-like enzyme
AU2001281969A1 (en) Regulation of human carboxylesterase-like enzyme
AU2001285782A1 (en) Regulation of human phosphodiesterase-like enzyme
AU2002215942A1 (en) Regulation of human carboxylesterase-like enzyme
AU2002210525A1 (en) Regulation of human phospholipase-like enzyme
AU2002210514A1 (en) Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme

Legal Events

Date Code Title Description
8364 No opposition during term of opposition